Register now to R3i !
Your login
Your password
Confirm your password
Your email
I agree to receive the R3i newsletter
The Initiative

Prof. Tan Chee Eng

Prof. Tan Chee Eng
Short Narrative Biography

Dr Tan Chee Eng is Consultant Endocrinologist at Gleneagles Medical Centre. Before starting private practice at Gleneagles Medical Centre in 2004, he was the Head of Department of Endocrinology at the Singapore General Hospital for 5 years. Whilst at SGH, he was responsible for starting up the first Lipid unit in Singapore and also pioneered the electronic medical record for diabetes mellitus consultation (DMCARE).

His medical career began in 1984 when he graduated with the Bachelor of Medicine & Surgery from the National University of Singapore (NUS).  Following that, Dr Tan did his Masters in Internal Medicine at NUS and PhD at the University of Glasgow.

Dr Tan is currently a member of the Lipid Guidelines committee, Ministry of Health. He is a founder member and member of the Executive Council for the Asian Pacific Society of Atherosclerosis and Vascular Disease since 1999. He is currently also on the executive committee, Regional Federation for Asia Pacific, International Atherosclerosis Society. He was previously involved in both the Lipid Guidelines and Diabetes guidelines committee of the Ministry of Health, Singapore. He was also a member of the Singapore Ministry of Health taskforce on obesity. Other past appointment includes Adjunct Associate Professor with the Centre for Molecular Epidemiology, National University of Singapore. Dr Tan is a practising endocrinologist and has been managing patients with diabetes mellitus, cholesterol problems and obesity for the past 25 years. Therefore he is a firm believer in the benefits of exercise, nutrition and lifestyle changes in management of chronic metabolic diseases.

He has published more than 90 articles in International peer-reviewed journals and spoken at more than 300 international and local symposiums. He was also on the International Steering committee of a few international collaborative studies on risk factors for heart disease and diabetes mellitus.